NCT06908070 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06908070
Title	Chemoradiotherapy With Surgery Followed by Consolidation Durvalumab (CROWD)
Acronym	CROWD
Recruitment	Recruiting
Gender	both
Phase	FDA approved
Variant Requirements	No
Sponsors	Idris Bahce
Indications	lung non-small cell carcinoma
Therapies	Durvalumab
Age Groups:	adult \| senior
Covered Countries	NLD

Filter rows:

Showing 1 to 1 of 1 entries

Facility	Status	City	State	Zip	Country	Details
Amsterdam UMC, location VU Medical center	RECRUITING	Amsterdam			Netherlands	Details

Showing 1 to 1 of 1 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT06908070Clinical Trial Detail